1. Симбирцев А.С. Цитокины: классификация и биологические функции. Цитокины и воспаление. 2004 – Т.2.
С. 16-21.

2. Jun-Ming Z., Jianxiong A., Cytokines, Inflammation, and Pain. International Anesthesiology Clinics. 2007. Vol.45, №2. Р. 27-37.

3.Griffin G., Krishna S., Cytokines in infectious diseases. Journal of the Royal College of Physicians of London. 1998, Vol.32, №3.  P. 195-198.

4. Targeting the "cytokine storm" for therapeutic benefit / R.V. D'Elia , et al.  Clinical and vaccine immunology. 2013. -Vol.20, №3. P. 319-327.

5. Herrington C. Hall P.F. Molecular and cellular themes in inflammation and immunology. The Journal of pathology. 2008. Vol.214, №2. P.123-125.

6. Симбирцев А.С. Цитокины – новая система регуляции защитных реакций организма. Цитокины  и воспаление. 2002.  № 1. С. 35–47.

7. Turrin N.P., Plata-Salaman C.R. Cytocine – cytokine interactions and the brain. Brain Res. Bull. 2000. V. 51, № 1
P. 3–9.

8. Julie A.S., Andreas J.P. Bioanalytical chemistry of cytokines – A review. Anal Chim Acta. 2015. Vol. 85, №3.
Р. 95-115.

9. Us D. Cytokine storm in avian influenza. Mikrobiyoloji bulteni. 2008. Vol. 42, № 2. P. 365-380.

10. Mechanisms of acute inflammatory lunq injury induced by abdominal sеpsis / B. Neumann, et al. Int. Immunol. – 1999. Vol. 11, № 2. P. 217–227.

11. Tecchio C., Cassatella M.A. Neutrophil-derived cytokines involved in physiological and pathological angiogenesis. Chem Immunol Allergy. 2014. Vol.  99,  №3. Р. 123–137.

12. Copeland K. T., Heeney J., T helper cell activation and human retroviral pathogenesis. Microb. Rev. 1996. Rev. 60. P. 724–742.

13. Сенников С.В., Сияков А.Н., Козлов В.А., Апельные варианты и изоформы цитокинов в диагностике и патогенезе имунологических состояний. Иммунология. 2002. № 4. С. 243–247.

14.  Into the eye of the cytokine storm.  J.R Tisoncik, et al. Microbiol. Mol. Biol. Rev. 2012. Vol. 76, № 1. P. 16-32.

15. Gaddi P.J., Yap G.S., Cytokine regulation of immunopathology in toxoplasmosis. /Immunol. Cell Biol. 2007. Vol. 85, № 2. P. 155-159.

16. Pitkaranta A., Nokso–Koivisto J., Tokala V., Lawered gields of virus–induced interferon production in leukocyte cultureg and risk of recurrent respiratory infections in children. J. Clin. Virol. 1999. Vol. 14, № 3. P. 199–205.

17. Scheerlinck Y. J-P., Yen H-H., Veterinary applications of cytokines. Vet. Immun. Immunopat. 2005. Vol. 108,
№ 1–2. P. 17–22.

18. Induction of interferon and interferon-induced antiviral effector genes following a primary bovine herpesvirus-1 (BHV-1) respiratory infection / R. Osman, et al.  J Gen Virol.- 2017. Vol. 98, № 7.  Р. 1831-1842.

19. Commins S.P., Borish, J.W., Steinke Immunologic messenger molecules: Cytokines, interferons, and chemokines.
J. Allerg. Clin. Immunol.  2010.  Vol. 125, № 2, supl. 2.  P. 53–72.

20. Ishikawa T. A, Morris P.L., multister kinase-based sertoli cell autocrine- аm plifesinq loop requlates prostoqlaudins, their receptors and cytokines. Endocrinology. 2006.  Vol. 147, № 4., P. 1706–1716.

21. Venteclef N., Delerive P. Interleukin – 1 receptror antagonist induction os an additional mechanism for liver receptor homolog–1 to negativelg regulate the hepatic acyte phase response. J. Biol. Chem. 2007. Vol. 282, № 7. P. 4393–4399.

22. Кетлинский С.А., Симбирцев А.С. Цитокины. – С Пб.: Изд. «Фолиант», 2008. 552 с.

23. Jaymie B.,. Drew H. B,  Andrew J. Cytokines in psoriasis. Cytokine. 2015. Vol. 73, №2. P. 342-350.

24. Ukai T., Yumoto H.,. Gibson F.C, Genco C.A. Macrophage–Elicited osteoclastogenis in Response to Bacterial Stimulation Reguires Toll–Like receptor 2–Dependent, Tumor Necrosis Factor–Alpha Production. Infect. Immun. 2008. Vol. 76, №2. P. 812–819.

25. Ahmed S., Ihara K., Sasaki Y. Cytokines and cytokine receptors in health and disease. Exp. Clin Immunogenet. – 2000. Vol. 17, №1. P. 18–22.

26. Daуer J.M., Molnarfi N., Burger D. From cellylar receptors to transduction transcription pathways for cytokines: at which level shoud the inhibition be targeted in inflammation. Exp. Opin. Biol. Ther. 2005. Sep. 5. Suppl. 1. P. 83–96.

27. Pace T.W., Miller A.H. Cytokines and glucocorticoid reseptor signaling. Relevance to major depression. Ann. N. Y. Acad. Sci. 2009. Vol. 1179, № 10. P. 86–105.

28. Ouyang S., He F. Phylogeny of a growth hormone-like cytokine superfamily based upon 3D structure. Journal of Molecular Evolution. 2003. Vol. 56. P. 131-136.

29. Locksley R.M., Killeen N., Leonardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology Cell. 2001. Vol. 104. № 8. P. 487-501.

30. Belardelli F., Ferrantini M. Cytokines as link between innate and adaptive antitumor immunity. Trend. Immunol. – 2002. Vol. 23, №4. P. 201–208.

31. Ветра Я.Я., Иванова Л.В., Крейле И.Э. Цитокины. Гематология и трансфузиол. 2000. Т. 45, № 4. С. 45–49.

32. Zhang X., Hester S.E., Kenntt M.J. Interleukin–1 receptor Signalinq Is Reguired To overcome the Effects of Pertussis Toxin and for Efficient Infection– or Vacination– Induced Immunity againt Bordetella pertussis. Infect. Immun. 2011. Vol. 79, № 4. P. 527–541.

33. Ярилин А.А. Контактные межклеточные взаимодействия при иммунном ответе. Мед. иммунология. 1999. № 4. С. 46–52.

34. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease /M.D.Turner, et al. Biochim Biophys Acta. 2014. Vol. 1843, № 11. Р. 2563-2582.

35. On the cytokines produced by human neutrophils in tumors C. Tecchio et al. Semin Cancer Biol.  2013. Vol. 23,  №3. Р. 159-170.

36. Ikram N., Hassan K., Tufail S. Cytokines. International Journal of Pathology. 2004. Vol.2. P. 47-58.

37. Bracci L., V. La Sorva, Belardelli F., Proietti E. Type 1 interferons as vaccine adjuvants against infections diseases and cancer. Expert. Rev. Vaccines. 2008. Vol. 7, №3. P. 373–381.

38. Stow J.L.,  Murray R.Z. Intracellular trafficking and secretion of inflammatory cytokines. Cytokine Growth Factor. 2013. Vol. 24, №3. Р. 227-239.

39. Mounts J.D., Wahg J.H., Xie S, Hsu H.C. Cytokine regulation of B–cell migratory behavior favors formation of germinal centers in autoimmune disease. Discov. Med. 2011. Vol. 11(56). P. 76–85.

40. O'Neill L. IL / versus TNF in artritis? Trends in Immunolog. 2001. Vol. 22, № 1. P. 353–354.

41. Qiang L., Yuan-hong Z.,  Zhan-qiu Y. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cellular and Molecular Immunology. 2016. Vol.13, №1. Р. 3-10.

42. Потапнев М.П. В – лимфоциты. Цитокинобразующая функція. Иммунология 1994. № 4. С. 4–8.

43. ..T cell subsets and their signature cytokines in autoimmune and inflammatory diseases/ I. Raphael,  et al. Cytokine. 2015.Vol.74, №1. Р. 5-17.

44. Two types of helper T cell clone 1. Definition according to profiles of lymphokine activites and secreted proteins / T.R. Masman, et al. J. Immunоl.  2005.  Vol. 175, № 1. P. 5–14.

45. Cytokine – modulated regulation of helper T – cell populations / A. Yates et al. J. Theo. Biol. 2000. Vol. 206.
P. 539–560.

46. Kelso A. Th 1 and Th 2 subsets: Paradiqms last Immunal Today. 1995. Vol. 16, № 8. P. 374–379.

47. Arango, D.G., Fukuda M., Descoteaux A. Synaptotagmin XI regulates phagocytosis and cytokine secretion in macrophages. J. Immunol. 2013. Vol. 190, №4. P. 1737–1745. 

48. The interleukin (IL)-1 cytokine family – Balance between agonists and antagonists in inflammatory diseases/ J. Palomo  et al. Cytokine. 2015.Vol.76, №1. Р. 25-37.

49. Romagnani S. Th 1 versus Th 2 responses in AiDS. Curr. Opin. Immunol. 1994. Vol. 6, № 4. Р. 616–622.

50. Galagher R. Tagqinq T cells: Th 1 or Th 2. Science. 1997. Vol. 275. P. 1615.

51. Zeng W.P., Chauq C., Lai J.J Immune suppressive activity and lack of T xelper differentiation are regylated in natural regulatoru T cells. J. Immunоl. 2009. Vol. 183, № 6. Р. 3583–3590.

52. Хаитов Р.М., Пинегин Б.В. Современные имуномодуляторы: основные принципы их применения. Иммунология. 2000. № 5. С. 4–7.

53. Taylor D.C., Cullen S.P., Martin S.J. Apoptasis: Controlled demolition at the cellular level. 2008. Vol. 9, № 3.
Р. 231–241.

54. O'Brien R.L., Roark C.L., Born W.K. IL – 17 – producting γδT cells. Eur. J. Immun. 2009. Vol. 39, № 3. Р. 662–666.

55. Autophagy and apoptosis: where do they meet?/ S. Mukhopadhyay. et al. Apoptosis. 2014. Vol. 19, №4. Р. 555-566.

56. Gaol. Y., Kwaik Y.A. The modulation of host cell apoptosis by intracellular bacterial patogenesis  Trends. Microb. – 2000. Vol. 8, № 7. Р. 306–313.

57. Потапнев М.П. Апоптоз клеток иммунной системы и его регуляция цитокинами. Иммунология. 2002. №4.
С. 5–9.

58. Barber G.N. The interferons and cell death: quardians of the cell or accomplices of apontosis ? Semin. Cancer Biol. 2000. Vol. 10, №2. Р. 103–111.

59. Heterogenoug susceptibility to CD95– induced apontosis sn melanoma cell correlates with b c l – 2 and b c l–x expression and is sensitive to modulation by interferon – gamma. / S. Uqurel, et al. Int. J. Cancer. 1999. Vol. 82, № 5.
Р. 727–736.

60. Molecular crosstalk between apoptosis, necroptosis, and survival signaling/ V. B. Tom , et al. Mol. Cell Oncol.  2015. Vol. 2, №2. P. 45-50.